University of Toronto researchers have identified two genes that play a critical role in tumor growth in the pancreas—findings that have significant implications for understanding and treating pancreatic cancer.
Jul 25, 2024
0
23
A study on live tissue cells is the first to reveal how channels that allow sodium to enter into breast cancer cells enable tumors to grow and spread.
Jul 25, 2024
0
3
Scientists have discovered how the dangerous respiratory syncytial virus (RSV) defuses our immune response and, in doing so, have pinpointed an exciting new target for drug developers.
Jul 18, 2024
0
10
A group of scientists are hopeful their research findings about how schizophrenia originates and develops over time in the brain will pave the way for targeted treatments and better diagnosis of the serious mental health ...
Jul 16, 2024
0
62
Despite high hopes, a drug that wipes out the namesake cell type associated with the disease eosinophilic esophagitis (EoE) doesn't make patients feel better and doesn't reverse tissue damage in their throats.
Jun 27, 2024
0
12
A team of investigators from UCLA has identified distinct patient preference-based profiles among men diagnosed with low-risk prostate cancer regarding their treatment options that could help enhance shared decision-making ...
Jul 25, 2024
0
0
Strong, flexible, gel-like tubes—created using a novel 3D printing technology—could improve outcomes for heart bypass patients by replacing the human and synthetic veins currently used in surgery to re-route blood flow, ...
Jul 25, 2024
0
22
An international study has discovered that people living with the neurodegenerative condition spinal muscular atrophy (SMA) are at higher risk of developing fatty liver disease, suggesting that SMA patients may face additional ...
Jul 17, 2024
0
0
Subcutaneous delivery of an anti-TNF inhibitor drug improved remission rates in patients with moderate-to-severe Crohn's disease and ulcerative colitis, according to recent phase 3 clinical trial results published in the ...
Jul 16, 2024
0
8
The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer's disease. Kisunla is an IV infusion therapy given once a month to people in the early stages of Alzheimer's, according to the ...
Jul 15, 2024
0
0
